Skip to main content

Zimmer Granted Summary Judgment In A Knee Replacement Case

Zimmer Granted Summary Judgment In A Knee Replacement Case

Zimmer Granted Summary Judgment In  A Knee Replacement Case

Introduction

In an order issued on February 4, Judge Arthur D. Spatt of the U.S. District Court for the Eastern District of New York granted summary judgment to Zimmer Inc. in a case involving its knee replacement system, finding that the plaintiff's injuries were not caused because of inadequate warnings regarding the device.

The federal judge found that the plaintiff failed to furnish sufficient evidence asserting that her implanting surgeon would have preferred a different knee replacement system had he been given enhanced warnings about the system's side-effects. The plaintiff underwent a total right knee replacement surgery on March 14, 2011, during which Zimmer's Gender Solutions Natural-Knee Flex System specifically designed for those who have hyperextension of the knee or high posterior tibial slope was used. She raised allegations about the adequacy of Zimmer’s warnings and filed a product liability lawsuit against Zimmer on February 20, 2014.

The Zimmer NexGen knee implant lawsuits were consolidated in 2011, as MDL No. 2272, In Re: Zimmer NexGen Knee Implant Products Liability Litigation, in the U.S. District Court for the Northern District of Illinois before Judge Rebecca R. Pallmeyer. There were reports about the plaintiffs and the defendant agreed to settle this 7-year-old litigation for an undisclosed amount.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!